Skip to main content
Clinical Trials/JPRN-jRCT1090220235
JPRN-jRCT1090220235
Completed
未知

Platelet-Rich Fibrin and Platelet-Rich Plasma use in arthroscopic meniscal repair - PRF&PRP in meniscal repair

KOSSMOS medical corporation kemmochi orthopaeic clinic0 sites26 target enrollmentDecember 24, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
meniscal injury of the knee
Sponsor
KOSSMOS medical corporation kemmochi orthopaeic clinic
Enrollment
26
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Plateletconcentrates, such as PRF, should be used in meniscal repair to enhance the healing process in the avascular portion of the meniscus. We believe that the use of preparations like PRP or PRF will become widespread because they are relatively easy to produce and safe to use. PRF and PRP are autologous, safe, and cost-effective sources of growth factors, and PRF can freely adapt its shape and act as a scaffold for the meniscal repair. Hence, PRF is effective as a new autologous transplantation technique for meniscus repair. Moreover, the use of PRF and PRP may be a promising alternative in meniscal surgery; however, further studies are required to support the present results.

Registry
who.int
Start Date
December 24, 2015
End Date
October 18, 2021
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
KOSSMOS medical corporation kemmochi orthopaeic clinic

Eligibility Criteria

Inclusion Criteria

  • The man and woman who has the adaptation of the meniscal repair having a symptom.

Exclusion Criteria

  • The case that was impossible of a meniscal suture. The case that it is assumed that a cartilage loss is remarkable and is not a symptom derived from a meniscus

Outcomes

Primary Outcomes

Not specified

Similar Trials